MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers

Acta Radiologica

Volumn 38, Issue 4 PART 2, 1997, Pages 665-676

  Wang, Chen ^a   Gordon, P B ^b   Hustvedt, S O ^b   Grant, D ^b   Tufte Sterud, A ^b   Martinsen, I ^b   Ahlstrom H ^a   Hemmingsson, A ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b NYCOMED IMAGING AS   (Norway)

Author keywords

Contrast medium; Manganese; MnDPDP; MR

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; EDETIC ACID; MANGANESE; N,N' BIS(PYRIDOXAL 5 PHOSPHATE)ETHYLENEDIAMINE N,N' DIACETIC ACID; N,N'-BIS(PYRIDOXAL-5-PHOSPHATE)ETHYLENEDIAMINE-N,N'-DIACETIC ACID; PYRIDOXAL 5 PHOSPHATE;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HISTOLOGY; HUMAN; INSTRUMENTATION; KIDNEY; LIVER; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; REFERENCE VALUE; SINGLE BLIND PROCEDURE; SPLEEN; STATISTICS; TIME;

ADULT; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EDETIC ACID; HUMANS; KIDNEY; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE; PANCREAS; PYRIDOXAL PHOSPHATE; REFERENCE VALUES; SINGLE-BLIND METHOD; SPLEEN; TIME FACTORS;

EID: 0031181298     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841859709172399     Document Type: Article

References (52)

1. AICHER P. K., LANIADO M., KOPP A. F., GRÖNEWÄLLER E., DUDA S. H. & CLAUSSEN C. D.: Mn-DPDP-enhanced MR imaging of malignant liver lesions. Efficacy and safety in 20 patients. J. Magn. Reson. Imaging 3 (1993), 731.
2. 2-induced endothelium-dependent relaxation in bovine mesenteric arteries. J. Pharmacol. Exp. Ther. 271 (1994), 609.
3. AUTTI T., RAININKO R., VANHANEN S. L. et al.: MRI of the normal brain from early childhood to middle age. Neuroradiology 36 (1994), 649.
4. BERNARDINO M. E., YOUNG S. W., LEE J. K. T. & WEINREB J. C.: Hepatic MR imaging with Mn-DPDP. Safety, image quality, and sensitivity. Radiology 183 (1992) 53.
5. BRUROK H., SCHØJTT J., BERG K., KARLSSON J. O. G. & JYNGE P.: Effects of manganese dipyridoxal diphosphate, dipyridoxal diphosphate, and manganese chloride on cardiac function. An experimental study in the Langendorff perfused rat heart. Invest. Radiol. 3 (1995), 159.
6. BUTHIEAU A. M. & AUTISSIER N.: Effects of manganese ions on thyroid function in rat. Arch. Toxicol. 54 (1983), 243.
7. 54Mn in the monkey. Studies of different parts of the central nervous system and other organs. J. Clin. Invest. 50 (1971), 9.
8. 54Mn in the rat, with special reference to the CNS. J. Exp. Physiol. 54 (1969), 322.
9. DINOTO D. R., KENNEDY C. D., JOHNSON J. A. et al.: Pharmacokinetics and biotransformation of the MRI liver contrast agent mangafodipir trisodium injection in normal male volunteers. 4th International ISSX Meeting, Seattle, Washington 8 (1995), 323.
10. ELIZONDO G., FRETZ C. J., STARK D. D. et al.: Preclinical evaluation of MnDPDP. New paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 178 (1991), 73.
11. FRIEDHEIM E., CORVI C., GRAZIANO J., DONNELLI T. & BRESLIN D.: Choroid plexus as protective sink for heavy metals? Lancet 1 (1983), 981.
12. GALLEZ B., BACIC B. & SWARTZ H. M.: Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP. Magn. Reson. Med. 35 (1996), 14.
13. GEHL H. B., URHAHN R., BOHNDORF K. et al.: Mn-DPDP in MR imaging of pancreatic adenocarcinoma. Initial clinical experience. Radiology 186 (1993), 795.
14. GEHL H. B., VORWEEK D., KLOSE K. C., RABER H. & GUENTHER R. W.: Mn-DPDP-enhanced imaging of the kidneys. First results of signal intensity changes and corticomedullary differentiation after low-dosage infusion. Radiology 177 (1990), 292.
15. GEHL H. B., WEISS H. D., MICHELSEN A. & SCHAFER R.: MRI of acute pancreatitis using MnDPDP. Quantification of pancreatic injury. Eur. Radiol. 5 (1995), 282.
16. GEHL H. B., VORWEEK D., KLOSE K. C., RABER H. & GUENTHER R. W.: Mn-DPDP, the first contrast agent for the pancreas? First results of dynamic evaluation of signal intensity increases after infusion of Mn-DPDP. Radiology 177 (1990), 326.
17. GIBALDI M. & PERRIER D.: Pharmacokinetics, 2nd edn. Marcel Dekker, New York 1982.
18. GRANT D., BLAZAK W. F. & BROWN G. L.: The reproductive toxicology of intravenously administered MnDPDP in the rat and rabbit. Acta Radiol. 38 (1997), 759.
19. GRANT D., TOFT K. G., MARTINSEN I. & ATZPODIEN E.: Tissue distribution and general safety of MnDPDP in male beagle dogs, with or without total common bile duct obstruction. Acta Radiol. 38 (1997), 732.
20. GRANT D., ZECH K. & HOLTZ E.: Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy. Invest. Radiol. 29 (1994), S249.
21. HAMM B., VOGL T. J., BRANDING G. et al.: Focal liver lesions. MR imaging with Mn-DPDP - initial clinical results in 40 patients. Radiology 182 (1992), 167.
22. HUSTVEDT S. O., GRANT D., SOUTHON T. E. & ZECH K.: Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration. Acta Radiol. 38 (1997), 690.
23. INGERSOLL R. T. & APOSHIAN H. V.: Choroid plexus sequesters manganese and controls its movement from blood to CSF. Toxicologist 12 (1992), 359.
24. JYNGE P., BRUROK H., ASPLUND A. et al.: Cardiovascular safety of MnDPDP. Experience from ex vivo and in vivo animal experiments. In: New developments in contrast agent research, p. 83. Edited by P. A. Rinck & R. N. Muller. Eur. Magn. Reson. Forum, Belgium 1995.
25. 2. Acta Radiol. 38 (1997), 740.
26. 2 in dogs with acute ischaemic heart failure. Acta Radiol. 38 (1997), 750.
27. KETTRITZ U., WARSHAUSER D. M., BROWN E. D., SCHULUND J. F., EISENBERG L. B. & SEMELKA R. C.: Enhancement of the normal pancreas. Comparison of manganese-DPDP and gadolinium chelate. Eur. Radiol. 6 (1996), 14.
28. LARSEN L. E. & GRANT D.: General toxicology of MnDPDP. Acta Radiol. 38 (1997), 770.
29. LEANDER P.: Liver-specific contrast media for MRI and CT. Experimental studies. Acta Radiol. Suppl. 396 (1995), 1.
30. LIM O. K., STARK D. D., LEESE P. T., PFEFFERBAUM A., ROCKLAGE S. M. & QUAY S. C.: Hepatobiliary MR imaging. First human experience with MnDPDP. Radiology 178 (1991), 79.
31. LUOMA K., RAININKO R., MUMMI P. & LUUKKONEN R.: Is the signal intensity of cerebrospinal fluid constant? Intensity measurements with high- and low-field magnetic resonance imagers. Magn. Reson. Imaging 11 (1993), 549.
32. MAHFOUZ A., COFFIN C., ZYLBERSZTEJN C., RAHMOUNI A., MATHIEU D. G. & VASILE N.: Mn-DPDP-enhanced MR imaging of the liver. Value of fat suppression and delayed imaging. Radiology 197 (1995), 176.
33. MARCHAL G., ZHANG X., NI Y., VANHECKE P., YU J. & BAERT A. L.: Comparison between Gd-DTPA, Gd-EOB-DTPA and Mn-DPDP in induced HCC in rats. Magn. Reson. Imaging 11 (1993), 665.
34. MITCHELL D. G., CUTWATER E. K., MATTEUCCI T, RUBIN D. L., CHEZMAR J. L. & SAINI S.: Adrenal gland enhancement at MR imaging with MnDPDP. Radiology 194 (1995), 783.
35. MURAKI A. S., CARVLIN M. J., FRANCISCO J., ROCKLAGE S. M. & QUAY S.: MR imaging signal enhancement of normal intracranial and extracranial structures. Application of Mn(DPDP) as an MR contrast agent in brain. Radiology 169 (1988), 339.
36. NEWLAND M. C. & WEISS B.: Persistent effects of manganese on effortful responding and their relationship to manganese accumulation in the primate globus pallidus. Toxicol. Appl. Pharmacol. 113 (1992), 87.
37. NI Y., MARCHAL G., ZHANG X. et al.: The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. Invest. Radiol. 28 (1993), 520.
38. NI Y., MARCHAL G., YU J. et al.: Experimental liver cancers. MnDPDP-enhanced rims in MR-microangiographic-histologic-correlation study. Radiology 188 (1993), 45.
39. 2. Acta Radiol. 38 (1997), 700.
40. 4 by young rats. Tissue accumulation and depletion. J. Toxicol. Environ. Health 7 (1981), 263.
41. ROFSKY N. M., WEINREB J. C., BERNARDINO M. E., YOUNG S. W., LEE J. K. T. & Noz M. E.: Hepatocellular tumors. Characterization with Mn-DPDP-enhanced imaging. Radiology 188 (1993), 53.
42. ROFSKY N. M. & WEINREB J. C.: Manganese (II) N,N′-dipyridoxylethylenediamine-N,N′-diacetate-5,5′- bis(phosphate). Clinical experience with a new contrast agent. Magn. Reson. Q. 8 (1992), 156.
43. ROWLAND M. & TUCKER G.: Symbols in pharmacokinetics. J. Pharmacokinet. Biopharm. 14 (1982), 7.
44. RUMMENY E., EHRENHEIM C., GEHL H. B. et al.: Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Invest. Radiol. 26 (1991), S142.
45. SCHROEDER H. A., BALASSA J. J. & TIPTON I. H.: Essential trace metals in man. Manganese, a study in homeostasis. J. Chronic Dis. 19 (1966), 545.
46. SOUTHON T. E., GRANT D., BJØRNERUD A. et al.: NMR relaxation studies with MnDPDP. Acta Radiol. 38 (1997), 708.
47. 2+. Magn. Reson. Med. 8 (1988), 293.
48. TIRKKONEN B., AUKRUST A., COUTURE E. et al: Physicochemical characterisation of mangafodipir trisodium. Acta Radiol. 38 (1997), 780.
49. TOFT K. G., HUSTVEDT S. O., GRANT D. et al.: Metabolism and pharmacokinetics of MnDPDP in man. Acta Radiol. 38 (1997), 677.
50. TREINEN K. A., GRAY T. J. B. & BLAZAK W. E: Developmental toxicity of mangafodipir trisodium and manganese chloride in Sprague-Dawley rats. Teratology 52 (1995), 109.
51. VOGL T. J., HAMM B., SCHNELL B. et al.: Mn-DPDP enhancement patterns of hepatocellular lesions on MR images. J. Magn. Reson. Imaging 3 (1993), 51.
52. ZHENG W., PERRY D. F., NELSON D. & APOSHIAN H. V.: Choroid plexus protects cerebrospinal fluid against toxic metals. FASEB J. 5 (1991), 2188.